Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Insights into Imaging
Published in: Insights into Imaging 6/2013

Open Access 01-12-2013 | Pictorial Review

Metabolic and storage lung diseases: spectrum of imaging appearances

Authors: Rahul D. Renapurkar, Jeffrey P. Kanne

Published in: Insights into Imaging | Issue 6/2013

Login to get access

Abstract

Metabolic and storage diseases constitute a heterogeneous group of disorders that occur in the setting of altered biochemical homeostasis. Many of these disorders affect the lungs, either exclusively or as part of a systemic syndrome. For example, amyloidosis can be limited to the tracheobronchial tree or involve the kidneys, lungs and heart. The indolent course of some of these disorders and the non-specific clinical symptoms often result in a diagnostic challenge. Imaging, particularly high-resolution computed tomography (HRCT), is an invaluable asset in the diagnosis of these clinical conditions. Some metabolic and storage diseases have characteristic HRCT appearances, helping narrow the differential diagnosis. Correlation of the radiological and histopathological findings of this group of diseases has also helped improve understanding of these disorders. In addition, CT can offer guidance when tissue sampling is warranted and aid in histopathological diagnosis. This article describes the pertinent clinical features of the more common metabolic and storage diseases affecting the lungs, illustrates their respective HRCT findings and provides the relevant differential diagnosis.

Teaching Points

  • • To recognise the various metabolic and storage lung diseases
  • • To identify the characteristic imaging findings in various metabolic and storage lung diseases
  • • To discuss the relevant differential diagnoses of each of these diseases
Literature
1.
Wang NS, Steele AA (1979) Pulmonary calcification: scanning electron microscopic and X-ray energy-dispersive analysis. Arch Pathol Lab Med 103(5):252–257PubMed
2.
Bendayan D, Barziv Y, Kramer MR (2000) Pulmonary calcifications: a review. Respir Med 94(3):190–193PubMedCrossRef
3.
Kuhlman JE, Ren H, Hutchins GM, Fishman EK (1989) Fulminant pulmonary calcification complicating renal transplantation: CT demonstration. Radiology 173(2):459–460PubMedCrossRef
4.
Weber CK, Friedrich JM, Merkle E et al (1996) Reversible metastatic pulmonary calcification in a patient with multiple myeloma. Ann Hematol 72(5):329–332PubMedCrossRef
5.
Kanne JP, Godwin JD, Takasugi JE, Schmidt RA, Stern EJ (2004) Diffuse pulmonary ossification. J Thorac Imaging 19(2):98–102PubMedCrossRef
6.
Lara JF, Catroppo JF, Kim DU, da Costa D (2005) Dendriform pulmonary ossification, a form of diffuse pulmonary ossification: report of a 26-year autopsy experience. Arch Pathol Lab Med 129(3):348–353PubMed
7.
8.
Woolley K, Stark P (1999) Pulmonary parenchymal manifestations of mitral valve disease. Radiographics 19(4):965–972PubMedCrossRef
9.
10.
Fernandez Crisosto CA, Quercia Arias O, Bustamante N, Moreno H, Uribe Echevarria A (2004) [Diffuse pulmonary ossification associated with idiopathic pulmonary fibrosis]. Arch Bronconeumol 40(12):595–598PubMedCrossRef
11.
Gevenois PA, Abehsera M, Knoop C, Jacobovitz D, Estenne M (1994) Disseminated pulmonary ossification in end-stage pulmonary fibrosis: CT demonstration. AJR Am J Roentgenol 162(6):1303–1304PubMedCrossRef
12.
Chung MJ, Lee KS, Franquet T, Muller NL, Han J, Kwon OJ (2005) Metabolic lung disease: imaging and histopathologic findings. Eur J Radiol 54(2):233–245PubMedCrossRef
13.
Ahari JE, Delaney M (2007) Dendriform pulmonary ossification: a clinical diagnosis with 14year follow-up. Chest 132(4):701s
14.
Silberstein EB, Vasavada PJ, Hawkins H (1985) Idiopathic pulmonary ossification with focal pulmonary uptake of technetium-99m HMDP bone scanning agent. Clin Nucl Med 10:436PubMedCrossRef
15.
Moran CA, Hochholzer L, Hasleton PS, Johnson FB, Koss MN (1997) Pulmonary alveolar microlithiasis. A clinicopathologic and chemical analysis of seven cases. Arch Pathol Lab Med 121(6):607–611PubMed
16.
Tachibana T, Hagiwara K, Johkoh T (2009) Pulmonary alveolar microlithiasis: review and management. Curr Opin Pulm Med 15(5):486–490PubMedCrossRef
17.
Balikian JP, Fuleihan FJ, Nucho CN (1968) Pulmonary alveolar microlithiasis: report of five cases with special reference to roentgen manifestations. Am J Roentgenol Radium Ther Nucl Med 103(3):509–518PubMedCrossRef
18.
Gasparetto EL, Tazoniero P, Escuissato DL, Marchiori E, Frare E, Silva RL, Sakamoto D (2004) Pulmonary alveolar microlithiasis presenting with crazy-paving pattern on high resolution CT. Br J Radiol 77(923):974–976PubMedCrossRef
19.
Spencer H (1984) Pathology of the lung, 4th edn. Pergamon, London, pp 740–744
20.
Hoshino H, Koba H, Inomata S et al (1998) Pulmonary alveolar microlithiasis: high-resolution CT and MR findings. J Comput Assist Tomogr 22(2):245–248.8PubMedCrossRef
21.
Korn MA, Schurawitzki H, Klepetko W, Burghuber OC (1992) Pulmonary alveolar microlithiasis: findings on high-resolution CT. AJR Am J Roentgenol 158(5):981–982PubMedCrossRef
22.
Deniz O, Ors F, Tozkoparan E et al (2005) High resolution computed tomographic features of pulmonary alveolar microlithiasis. Eur J Radiol 55(3):452–460PubMedCrossRef
23.
Verma BN (1963) Pulmonary alveolar microlithiasis in a child of thirteen years. Br J Dis Chest 57:213–215PubMedCrossRef
24.
Weinstein DS (1999) Pulmonary sarcoidosis: calcified micronodular pattern simulating pulmonary alveolar microlithiasis. J Thorac Imaging 14(3):218–220PubMedCrossRef
25.
Saputo V, Zocchi M, Mancosu M, Bonaldi U, Croce P (1979) Pulmonary alveolar microlithiasis: a case report with a discussion of differential diagnosis. Helv Paediatr Acta 34(3):245–255PubMed
26.
Coolens JL, Devos P, De Roo M (1985) Diffuse pulmonary uptake of 99mTc bone-imaging agents: case report and survey. Eur J Nucl Med 11(1):36–42PubMedCrossRef
27.
Utz JP, Swensen SJ, Gertz MA (1996) Pulmonary amyloidosis: the Mayo Clinic experience from 1980 to 1993. Ann Intern Med 124(4):407–413PubMedCrossRef
28.
29.
Kyle RA, Gertz MA (1995) Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 32(1):45–59PubMed
30.
Gertz MA, Kyle RA (1989) Primary systemic amyloidosis: a diagnostic primer. Mayo Clin Proc 64(12):1505–1519PubMedCrossRef
31.
O’Regan A, Felon HM, Beamis JF Jr, Steele MP, Skinner M, Berk JL (2000) Tracheobronchial amyloidosis: the Boston University experience from 1984 to 1999. Med (Baltimore) 79(2):69–79CrossRef
32.
Kirchner J, Jacobi V, Kardos P, Kollath J (1998) CT findings in extensive tracheobronchial amyloidosis. Eur Radiol 8(3):352–354PubMedCrossRef
33.
Kim HY, Im JG, Song KS et al (1999) Localized amyloidosis of the respiratory system: CT features. J Comput Assist Tomogr 23(4):627–631PubMedCrossRef
34.
Kwong JS, Muller NL, Miller RR (1992) Diseases of the trachea and main-stem bronchi: correlation of CT with pathologic findings. Radiographics 12(4):645–657PubMedCrossRef
35.
Kwong JS, Adler BD, Padley SP, Muller NL (1993) Diagnosis of diseases of the trachea and main bronchi: chest radiography vs CT. AJR Am J Roentgenol 161(3):519–522PubMedCrossRef
36.
Ohkubo Y, Narimatsu A, Higuchi M et al (1990) [CT findings of the benign tracheobronchial lesions with calcification]. Rinsho Hoshasen 35(7):839–846PubMed
37.
Im JG, Chung JW, Han SK, Han MC, Kim CW (1988) CT manifestations of tracheobronchial involvement in relapsing polychondritis. J Comput Assist Tomogr 12(5):792–793PubMedCrossRef
38.
39.
Aylwin AC, Gishen P, Copley SJ (2005) Imaging appearance of thoracic amyloidosis. J Thorac Imaging 20(1):41–46PubMedCrossRef
40.
Himmelfarb E, Wells S, Rabinowitz JG (1977) The radiologic spectrum of cardiopulmonary amyloidosis. Chest 72(3):327–332PubMedCrossRef
41.
Jeong YJ, Lee KS, Chung MP et al (2004) Amyloidosis and lymphoproliferative disease in Sjögren syndrome: thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr 28(6):776–781PubMedCrossRef
42.
Pickford HA, Swensen SJ, Utz JP (1997) Thoracic cross-sectional imaging of amyloidosis. AJR Am J Roentgenol 168(2):351–355PubMedCrossRef
43.
Aichaouia C, Ben Meftah MR, M’hamdi S et al (2010) Pleural amyloidosis attesting to generalised amyloidosis]. Rev Pneumol Clin 66(3):204–208PubMedCrossRef
44.
Mekinian A, Jaccard A, Soussan M, Launay D, Berthier S, Federici L, Lefèvre G, Valeyre D, Dhote R, Fain O (2012) 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review. Amyloid 19(2):94–98PubMedCrossRef
45.
Schaadt BK, Hendel HW, Gimsing P, Jønsson V, Pedersen H, Hesse B (2000) 99mTc aprotinin scintigraphy in amyloidosis. J Nucl Med 44(2):177–183
46.
47.
Ben Dov I, Kishinevski Y, Roznman J et al (1999) Pulmonary alveolar proteinosis Israel: ethnic clustering. Isr Med Assoc J 1(2):75–78PubMed
48.
49.
Inoue Y, Trapnell BC, Tazawa R et al (2008) Japanese Center of the Rare Lung Diseases Consortium. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 177(7):752–762PubMedPubMedCentralCrossRef
50.
Seymour JF, Presneill JJ (2002) Pulmonary alveolar proteinosis: progress in the first 44years. Am J Respir Crit Care Med 166(2):215–235PubMedCrossRef
51.
Burbank B, Morrione TG, Cutler SS (1960) Pulmonary alveolar proteinosis and nocardiosis. Am J Med 28:1002–1007PubMedCrossRef
52.
Murch CR, Carr DH (1989) Computed tomography appearances of pulmonary alveolar proteinosis. Clin Radiol 40(3):240–243PubMedCrossRef
53.
Frazier AA, Franks TJ, Cooke EO, Mohammed TL, Pugatch RD, Galvin JR (2008) From the archives of the AFIP: pulmonary alveolar proteinosis. Radiographics 28(3):883–899PubMedCrossRef
54.
Miller PA, Ravin CE, Smith GJ, Osborne DR (1981) Pulmonary alveolar proteinosis with interstitial involvement. AJR Am J Roentgenol 137(5):1069–1071PubMedCrossRef
55.
56.
Hsu CW, Liu FY, Wang CW, Lin HC, Huang CD (2009) F-18 FDG PET/CT in pulmonary alveolar proteinosis. Clin Nucl Med 34(2):103–104PubMedCrossRef
57.
Venkateshiah SB, Yan TD, Bonfield TL, Thomassen MJ, Meziane M, Czich C, Kavuru MS (2006) An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest 130(1):227–237PubMedCrossRef
58.
Kavuru MS, Malur A, Marshall I et al (2011) An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J 38(6):1361–1367PubMedCrossRef
59.
Cox TM (2001) Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis 24(Suppl 2):106–121PubMed
60.
Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281(3):249–254PubMedCrossRef
61.
Goitein O, Elstein D, Abrahamov A et al (2001) Lung involvement and enzyme replacement therapy in Gaucher’s disease. QJM 94(8):407–415PubMedCrossRef
62.
Yassa NA, Wilcox AG (1998) High-resolution CT pulmonary findings in adults with Gaucher’s disease. Clin Imaging 22(5):339–342PubMedCrossRef
63.
Copley SJ, Coren M, Nicholson AG, Rubens MB, Bush A, Hansell DM (2000) Diagnostic accuracy of thin-section CT and chest radiography of pediatric interstitial lung disease. AJR Am J Roentgenol 174(2):549–554PubMedCrossRef
64.
Roberts WC, Frederickson DS (1967) Gaucher’s disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis. Circulation 35(4):783–789PubMedCrossRef
65.
Kim JH, Park CH, Pai MS, Hahn MH, Kim HJ (1999) Hepatopulmonary syndrome in Gaucher disease with right-to-left shunt: evaluation and measurement using Tc-99m MAA. Clin Nucl Med 24(3):164–166PubMedCrossRef
66.
Gülhan B, Özçelik U, Gürakan F et al (2012) Different features of lung involvement in Niemann-Pick disease and Gaucher disease. Respir Med 106:1278–1285PubMedCrossRef
67.
Lo S, Liu J, Chen F et al (2011) Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy. J Inherit Metab Dis 34(3):643–650PubMedPubMedCentralCrossRef
68.
Nicholson AG, Florio R, Hansell DM et al (2006) Pulmonary involvement by Niemann-Pick disease. A report of six cases. Histopathology 48(5):596–603PubMedCrossRef
69.
Sevin M, Lesca G, Baumann N et al (2007) The adult form of Niemann-Pick disease type C. Brain 130(Pt 1):120–133PubMed
70.
Skikne MI, Prinsloo I, Webster I (1972) Electron microscopy of lung in Niemann-Pick disease. J Pathol 106(2):119–122PubMedCrossRef
71.
Ferretti GR, Lantuejoul S, Brambilla E, Coulomb M (1996) Case report. Pulmonary involvement in Niemann-Pick disease subtype B: CT findings. J Comput Assist Tomogr 20(6):990–992PubMedCrossRef
72.
Nicholson AG, Wells AU, Hooper J et al (2002) Successful treatment of endogenous lipoid pneumonia due to Niemann–Pick type B disease with whole-lung lavage. Am J Respir Crit Care Med 165(1):128–131PubMedCrossRef
73.
Hermansky F, Pudlak P (1959) Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. Blood 14(2):162–169PubMed
74.
Witkop CJ, Nunez Babcock M, Rao GH et al (1990) Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Assoc Med PR 82(8):333–339
75.
Pierson DM, Ionescu D, Qing G et al (2006) Pulmonary fibrosis in Hermansky-Pudlak syndrome. A case report and review. Respiration 73(3):382–395PubMedCrossRef
76.
Huizing M, Gahl WA (2002) Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med 2(5):451–467PubMedCrossRef
77.
Nakatani Y, Nakamura N, Sano J et al (2000) Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes. Virchows Arch 437(3):304–313PubMedCrossRef
78.
Mahavadi P, Guenther A, Gochuico BR (2012) Hermansky-Pudlak syndrome interstitial pneumonia: it’s the epithelium, stupid! Am J Respir Crit Care Med 186(10):939–940PubMedPubMedCentralCrossRef
79.
Avila NA, Brantly M, Premkumar A, Huizing M, Dwyer A, Gahl WA (2002) Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies. AJR Am J Roentgenol 179(4):887–892PubMedCrossRef
80.
Lederer DJ, Kawut SM, Sonett JR, Vakiani E, Seward SL, White JG, Wilt JS, Marboe CC, Gahl WA, Arcasoy SM (2005) Successful bilateral lung transplantation for pulmonary fibrosis associated with Hermansky-Pudlak syndrome. J Heart Lung Transplant 24:1697–1699PubMedCrossRef
Metadata
Title
Metabolic and storage lung diseases: spectrum of imaging appearances
Authors
Rahul D. Renapurkar
Jeffrey P. Kanne
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 6/2013
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-013-0289-x

Other articles of this Issue 6/2013

Insights into Imaging 6/2013 Go to the issue

Pictorial Review

Non-contrast 3D MR lymphography of retroperitoneal lymphatic aneurysmal dilatation: a continuous spectrum of change from normal variants to cystic lymphangioma

Review

Radiography, tomosynthesis, CT and MRI in the evaluation of pulmonary cystic fibrosis: an untangling review of the multitude of scoring systems

Pictorial Review

Ultrasound assessment of acute appendicitis in paediatric patients: methodology and pictorial overview of findings seen

Review

Imaging in rheumatology: reconciling radiology and rheumatology

Pictorial Review

The anatomical compartments and their connections as demonstrated by ectopic air

Statement

The strategy of ESR and Insights into Imaging regarding the application for an impact factor